Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Professional Survey Report 2016

  • QYR686321
  • 119 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Production, means the output of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Revenue, means the sales value of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

This report studies Non-alcoholic Fatty Liver Disease (NAFLD) Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Conatus Pharmaceuticals

Daewoong Pharmaceutical

Galmed International

Kyorin Pharmaceutical

Metabolic Solutions Development

Novartis AG

Phenex Pharmaceuticals

Raptor Pharmaceuticals

TCM Biotech International

Tobira Therapeutics

Verva Pharmaceuticals

Zafgen

By types, the market can be split into

Type I

Type II

Type III

By Application, the market can be split into

Application 1

Application 2

Application 3

By Regions, this report covers (we can add the regions/countries as you want)

North America

China

Europe

Southeast Asia

Japan

India

Table of Contents

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Professional Survey Report 2016

1 Industry Overview of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

1.1 Definition and Specifications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

1.1.1 Definition of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

1.1.2 Specifications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

1.2 Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Applications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Market Segment by Regions

1.4.1 North America

1.4.2 China

1.4.3 Europe

1.4.4 Southeast Asia

1.4.5 Japan

1.4.6 India

2 Manufacturing Cost Structure Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

2.1 Raw Material and Suppliers

2.2 Manufacturing Cost Structure Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

2.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

2.4 Industry Chain Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

3 Technical Data and Manufacturing Plants Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

3.1 Capacity and Commercial Production Date of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015

3.2 Manufacturing Plants Distribution of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015

3.3 R&D Status and Technology Source of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015

3.4 Raw Materials Sources Analysis of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015

4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overall Market Overview

4.1 2011-2016E Overall Market Analysis

4.2 Capacity Analysis

4.2.1 2011-2016E Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity and Growth Rate Analysis

4.2.2 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Analysis (Company Segment)

4.3 Sales Analysis

4.3.1 2011-2016E Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate Analysis

4.3.2 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Analysis (Company Segment)

4.4 Sales Price Analysis

4.4.1 2011-2016E Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price

4.4.2 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis (Company Segment)

5 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Regional Market Analysis

5.1 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis

5.1.1 North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview

5.1.2 North America 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis

5.1.3 North America 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis

5.1.4 North America 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis

5.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis

5.2.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview

5.2.2 China 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis

5.2.3 China 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis

5.2.4 China 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis

5.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis

5.3.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview

5.3.2 Europe 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis

5.3.3 Europe 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis

5.3.4 Europe 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis

5.4 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis

5.4.1 Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview

5.4.2 Southeast Asia 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis

5.4.3 Southeast Asia 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis

5.4.4 Southeast Asia 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis

5.5 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis

5.5.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview

5.5.2 Japan 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis

5.5.3 Japan 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis

5.5.4 Japan 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis

5.6 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Analysis

5.6.1 India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview

5.6.2 India 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Local Supply, Import, Export, Local Consumption Analysis

5.6.3 India 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Analysis

5.6.4 India 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Share Analysis

6 Global 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Segment Market Analysis (by Type)

6.1 Global 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type

6.2 Different Types of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price Analysis

6.3 Different Types of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Driving Factors Analysis

6.3.1 Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis

6.3.2 Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis

6.3.3 Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis

7 Global 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Segment Market Analysis (by Application)

7.1 Global 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption by Application

7.2 Different Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price Analysis

7.3 Different Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Driving Factors Analysis

7.3.1 Application 1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis

7.3.2 Application 2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis

7.3.3 Application 3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

8.1 Conatus Pharmaceuticals

8.1.1 Company Profile

8.1.2 Product Picture and Specifications

8.1.2.1 Type I

8.1.2.2 Type II

8.1.2.3 Type III

8.1.3 Conatus Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.1.4 Conatus Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis

8.2 Daewoong Pharmaceutical

8.2.1 Company Profile

8.2.2 Product Picture and Specifications

8.2.2.1 Type I

8.2.2.2 Type II

8.2.2.3 Type III

8.2.3 Daewoong Pharmaceutical 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.2.4 Daewoong Pharmaceutical 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis

8.3 Galmed International

8.3.1 Company Profile

8.3.2 Product Picture and Specifications

8.3.2.1 Type I

8.3.2.2 Type II

8.3.2.3 Type III

8.3.3 Galmed International 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.3.4 Galmed International 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis

8.4 Kyorin Pharmaceutical

8.4.1 Company Profile

8.4.2 Product Picture and Specifications

8.4.2.1 Type I

8.4.2.2 Type II

8.4.2.3 Type III

8.4.3 Kyorin Pharmaceutical 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.4.4 Kyorin Pharmaceutical 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis

8.5 Metabolic Solutions Development

8.5.1 Company Profile

8.5.2 Product Picture and Specifications

8.5.2.1 Type I

8.5.2.2 Type II

8.5.2.3 Type III

8.5.3 Metabolic Solutions Development 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.5.4 Metabolic Solutions Development 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis

8.6 Novartis AG

8.6.1 Company Profile

8.6.2 Product Picture and Specifications

8.6.2.1 Type I

8.6.2.2 Type II

8.6.2.3 Type III

8.6.3 Novartis AG 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.6.4 Novartis AG 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis

8.7 Phenex Pharmaceuticals

8.7.1 Company Profile

8.7.2 Product Picture and Specifications

8.7.2.1 Type I

8.7.2.2 Type II

8.7.2.3 Type III

8.7.3 Phenex Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.7.4 Phenex Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis

8.8 Raptor Pharmaceuticals

8.8.1 Company Profile

8.8.2 Product Picture and Specifications

8.8.2.1 Type I

8.8.2.2 Type II

8.8.2.3 Type III

8.8.3 Raptor Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.8.4 Raptor Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis

8.9 TCM Biotech International

8.9.1 Company Profile

8.9.2 Product Picture and Specifications

8.9.2.1 Type I

8.9.2.2 Type II

8.9.2.3 Type III

8.9.3 TCM Biotech International 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.9.4 TCM Biotech International 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis

8.10 Tobira Therapeutics

8.10.1 Company Profile

8.10.2 Product Picture and Specifications

8.10.2.1 Type I

8.10.2.2 Type II

8.10.2.3 Type III

8.10.3 Tobira Therapeutics 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.10.4 Tobira Therapeutics 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis

8.11 Verva Pharmaceuticals

8.11.1 Company Profile

8.11.2 Product Picture and Specifications

8.11.2.1 Type I

8.11.2.2 Type II

8.11.2.3 Type III

8.11.3 Verva Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.11.4 Verva Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis

8.12 Zafgen

8.12.1 Company Profile

8.12.2 Product Picture and Specifications

8.12.2.1 Type I

8.12.2.2 Type II

8.12.2.3 Type III

8.12.3 Zafgen 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.12.4 Zafgen 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution Analysis

9 Development Trend of Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market

9.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Trend Analysis

9.1.1 Global 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Volume and Value) Forecast

9.1.2 Global 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Forecast

9.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Regional Market Trend

9.2.1 North America 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast

9.2.2 China 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast

9.2.3 Europe 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast

9.2.4 Southeast Asia 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast

9.2.5 Japan 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast

9.2.6 India 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Forecast

9.3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Trend (Product Type)

9.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Trend (Application)

10 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Marketing Type Analysis

10.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Regional Marketing Type Analysis

10.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug International Trade Type Analysis

10.3 Traders or Distributors with Contact Information of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions

10.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Supply Chain Analysis

11 Consumers Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

11.1 Consumer 1 Analysis

11.2 Consumer 2 Analysis

11.3 Consumer 3 Analysis

11.4 Consumer 4 Analysis

12 Conclusion of the Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Professional Survey Report 2016

Author List

Table Part of Interviewees Record List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List of Tables and Figures

Figure Picture of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Table Product Specifications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Table Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Figure Global Production Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Type in 2015

Table Applications of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Figure Global Consumption Volume Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Application in 2015

Figure Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions

Figure North America Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)

Figure China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)

Figure Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)

Figure Southeast Asia Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)

Figure Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)

Figure India Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (2011-2021)

Table Non-alcoholic Fatty Liver Disease (NAFLD) Drug Raw Material and Suppliers

Table Manufacturing Cost Structure Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug in 2015

Figure Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Figure Industry Chain Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

Table Capacity (Kg) and Commercial Production Date of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015

Table Manufacturing Plants Distribution of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015

Table R&D Status and Technology Source of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015

Table Raw Materials Sources Analysis of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015

Table Global Capacity (Kg), Sales (Kg), Price (USD/g), Cost (USD/g), Sales Revenue (M USD) and Gross Margin of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2011-2016

Figure Global 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Volume) and Growth Rate

Figure Global 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Value) and Growth Rate

Table 2011-2016E Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity and Growth Rate

Table 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity List (Company Segment)

Table 2011-2016E Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate

Table 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales List (Company Segment)

Table 2011-2016E Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price

Table 2015 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price List (Company Segment)

Figure North America Capacity Overview

Table North America Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2011-2016 (Kg)

Figure North America 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price (USD/g)

Figure North America 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share

Figure China Capacity Overview

Table China Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2011-2016 (Kg)

Figure China 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price (USD/g)

Figure China 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share

Figure Europe Capacity Overview

Table Europe Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2011-2016 (Kg)

Figure Europe 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price (USD/g)

Figure Europe 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share

Figure Southeast Asia Capacity Overview

Table Southeast Asia Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2011-2016 (Kg)

Figure Southeast Asia 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price (USD/g)

Figure Southeast Asia 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share

Figure Japan Capacity Overview

Table Japan Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2011-2016 (Kg)

Figure Japan 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price (USD/g)

Figure Japan 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share

Figure India Capacity Overview

Table India Supply, Import, Export and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug 2011-2016 (Kg)

Figure India 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price (USD/g)

Figure India 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Share

Table Global 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Type

Table Different Types Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price

Table Global 2011-2016E Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales by Application

Table Different Application Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Interview Price

Table Conatus Pharmaceuticals Information List

Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table 2015 Conatus Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price

Figure 2015 Conatus Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution

Table Daewoong Pharmaceutical Information List

Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table 2015 Daewoong Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price

Figure 2015 Daewoong Pharmaceutical 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution

Table Galmed International Information List

Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table 2015 Galmed International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price

Figure 2015 Galmed International 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution

Table Kyorin Pharmaceutical Information List

Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table 2015 Kyorin Pharmaceutical Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price

Figure 2015 Kyorin Pharmaceutical 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution

Table Metabolic Solutions Development Information List

Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table 2015 Metabolic Solutions Development Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price

Figure 2015 Metabolic Solutions Development 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution

Table Novartis AG Information List

Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table 2015 Novartis AG Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price

Figure 2015 Novartis AG 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution

Table Phenex Pharmaceuticals Information List

Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table 2015 Phenex Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price

Figure 2015 Phenex Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution

Table Raptor Pharmaceuticals Information List

Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table 2015 Raptor Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price

Figure 2015 Raptor Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution

Table TCM Biotech International Information List

Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table 2015 TCM Biotech International Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price

Figure 2015 TCM Biotech International 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution

Table Tobira Therapeutics Information List

Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table 2015 Tobira Therapeutics Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price

Figure 2015 Tobira Therapeutics 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution

Table Verva Pharmaceuticals Information List

Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table 2015 Verva Pharmaceuticals Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price

Figure 2015 Verva Pharmaceuticals 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution

Table Zafgen Information List

Table Type I Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type II Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table Type III Non-alcoholic Fatty Liver Disease (NAFLD) Drug Overview

Table 2015 Zafgen Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue, Sales, Ex-factory Price

Figure 2015 Zafgen 2015 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Business Region Distribution

Figure Global 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Volume) and Growth Rate Forecast

Figure Global 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Size (Value) and Growth Rate Forecast

Figure Global 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price (USD/g) Forecast

Figure North America 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast

Figure China 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast

Figure Europe 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast

Figure Southeast Asia 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast

Figure Japan 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast

Figure India 2016-2021 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume and Growth Rate Forecast

Table Global Sales Volume (Kg) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Types 2016-2021

Table Global Consumption Volume (Kg) of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Applications 2016-2021

Table Traders or Distributors with Contact Information of Non-alcoholic Fatty Liver Disease (NAFLD) Drug by Regions

Table Part of Interviewees Record List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370